Oxidized lipid depresses canine growth, immune function, and bone formation.
Dietary oxidized lipids can increase oxidative stress and potentially contribute to a variety of disease syndromes. This research describes the first use of a canine model to assess the effects of dietary oxidized lipids on growth, antioxidant status, and some immune functions. Three groups of eight, two-month old coon-hound puppies were pair fed diets for 16 weeks. The control diet contained <50 ppm aldehydes, and two additional diets contained thermally oxidized lipids targeted to contain 100 ppm aldehydes (medium-oxidation) and 500 ppm aldehydes (high-oxidation). Dogs fed the high-oxidation diet weighed less than those from the medium-oxidation (P < 0.05) and control groups (P < 0.001) at the end of the study. Oxidized lipids reduced serum vitamin E levels, total body fat content, and bone appositional rate. At different time points of the study, peripheral blood neutrophils and monocytes from dogs fed the HO diet had reduced oxidative burst capacity and produced less superoxide and hydrogen peroxide when stimulated with phorbol esters compared to the control group. Lymphocyte blastogenesis in response to concanavalin A was suppressed by dietary oxidized lipid. This study indicates that dietary oxidized lipids negatively affect the growth, antioxidant status, and some immune functions of dogs. Importantly, some effects are evident at 100 ppm aldehydes in the diet, which is a moderate level of oxidation. The rapid growth and weight gain of the dog during the first 6 months of life may also provide a better model for assessing the risks of dietary oxidized lipid in children and adolescents than previously used rodent models.
Turek
John J
JJ
Department of Basic Medical Sciences, School of Veterinary Medicine, Purdue University, W. Lafayette, IN 47907, USA. turekj@purdue.edu
Watkins
Bruce A
BA
Schoenlein
Ingrid A
IA
Allen
Kenneth G D
KG
Hayek
Michael G
MG
Aldrich
C Gregory
CG
D000447:Aldehydes / Q000032:analysis; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D004032:Diet; D015232:Dinoprostone / Q000096:biosynthesis; D004285:Dogs; D005227:Fatty Acids / Q000032:analysis; D006128:Growth / Q000187:drug effects*; D007107:Immune System / Q000187:drug effects*; D015227:Lipid Peroxidation; D008055:Lipids / Q000009:adverse effects*; D008213:Lymphocyte Activation / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects*; D016897:Respiratory Burst / Q000187:drug effects; D015430:Weight Gain / Q000187:drug effects
D000447:Aldehydes; D005227:Fatty Acids; D008055:Lipids; D015232:Dinoprostone